• IFAPP

    Established in 1975, IFAPP works to advance the discipline of Pharmaceutical Medicine and Medicines Development as a profession to the benefit of patients and Public Health worldwide.

Read More..

Anna Jurczynska

about-us

Anna Jurczynska

Independent consultant, co-founder of ANMAR Clinical Services.

Dr. Jurczynska is MBA from the University of Warsaw and PhD on Social Sciences with specialization in Health Care. She has a broad experience in pharmaceutical industry (Upjohn Farmoquimica, Serono and IMTIX Sangstat) in Medical, Regulatory, Medical Science Liaison and Marketing Departments. Her main commitments were related to local and clinical operations while in the Medical Department, with large responsibility for timely submission of Clinical Trials dossiers, correct performance and adequate outcomes and results of the trials. In Regulatory Department, she was accountable for the supervision and development of new product registration dossiers for submission to Spanish Health Authorities and/or to EMA. Her position in MSL and Marketing Departments was mainly related to contacts with Key Opinion Leaders, development of clinical protocols for post-authorization studies and organization of congresses, conferences and similar events.  Dr. Jurczynska had a direct responsibility as General Manager of Business Administration at PAREXEL International, being its legal representative in Spain and overseeing all clinical and business operations in the country. Currently she is Program Director at the Spanish Association of Pharmaceutical Medicine (AMIFE) and General Secretary at the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP).

panels_data:
a:3:{s:7:"widgets";a:4:{i:0;a:13:{s:5:"image";i:2512;s:14:"image_fallback";s:0:"";s:4:"size";s:4:"full";s:5:"align";s:7:"default";s:5:"title";s:0:"";s:14:"title_position";s:6:"hidden";s:3:"alt";s:0:"";s:3:"url";s:0:"";s:5:"bound";b:1;s:12:"_sow_form_id";s:13:"581adc0357764";s:10:"new_window";b:0;s:10:"full_width";b:0;s:11:"panels_info";a:7:{s:5:"class";s:30:"SiteOrigin_Widget_Image_Widget";s:3:"raw";b:0;s:4:"grid";i:0;s:4:"cell";i:0;s:2:"id";i:0;s:9:"widget_id";s:36:"fb81bc7a-4f00-4820-af97-7b92b5578097";s:5:"style";a:1:{s:18:"background_display";s:4:"tile";}}}i:1;a:4:{s:5:"title";s:0:"";s:4:"text";s:327:"";s:6:"filter";b:0;s:11:"panels_info";a:7:{s:5:"class";s:14:"WP_Widget_Text";s:3:"raw";b:0;s:4:"grid";i:0;s:4:"cell";i:0;s:2:"id";i:1;s:9:"widget_id";s:36:"193651cc-b478-477d-ba9e-fdf4cfe69e7c";s:5:"style";a:1:{s:18:"background_display";s:4:"tile";}}}i:2;a:7:{s:5:"title";s:0:"";s:4:"text";s:1806:"

Anna Jurczynska

Independent consultant, co-founder of ANMAR Clinical Services.

Dr. Jurczynska is MBA from the University of Warsaw and PhD on Social Sciences with specialization in Health Care. She has a broad experience in pharmaceutical industry (Upjohn Farmoquimica, Serono and IMTIX Sangstat) in Medical, Regulatory, Medical Science Liaison and Marketing Departments. Her main commitments were related to local and clinical operations while in the Medical Department, with large responsibility for timely submission of Clinical Trials dossiers, correct performance and adequate outcomes and results of the trials. In Regulatory Department, she was accountable for the supervision and development of new product registration dossiers for submission to Spanish Health Authorities and/or to EMA. Her position in MSL and Marketing Departments was mainly related to contacts with Key Opinion Leaders, development of clinical protocols for post-authorization studies and organization of congresses, conferences and similar events.  Dr. Jurczynska had a direct responsibility as General Manager of Business Administration at PAREXEL International, being its legal representative in Spain and overseeing all clinical and business operations in the country. Currently she is Program Director at the Spanish Association of Pharmaceutical Medicine (AMIFE) and General Secretary at the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP).

";s:20:"text_selected_editor";s:4:"tmce";s:5:"autop";b:1;s:12:"_sow_form_id";s:13:"581aece8d4f90";s:19:"_sow_form_timestamp";s:0:"";s:11:"panels_info";a:6:{s:5:"class";s:31:"SiteOrigin_Widget_Editor_Widget";s:4:"grid";i:1;s:4:"cell";i:1;s:2:"id";i:2;s:9:"widget_id";s:36:"c7ad20fc-0f04-4264-9d3d-77a3ba21ba9b";s:5:"style";a:2:{s:27:"background_image_attachment";b:0;s:18:"background_display";s:4:"tile";}}}i:3;a:6:{s:5:"title";s:0:"";s:4:"text";s:22:"[widget id="search-2"]";s:20:"text_selected_editor";s:4:"html";s:5:"autop";b:1;s:12:"_sow_form_id";s:13:"581af4b710ab3";s:11:"panels_info";a:7:{s:5:"class";s:31:"SiteOrigin_Widget_Editor_Widget";s:3:"raw";b:0;s:4:"grid";i:1;s:4:"cell";i:2;s:2:"id";i:3;s:9:"widget_id";s:36:"b1ec6397-34ad-40dd-b4cd-d89b5b22dd6f";s:5:"style";a:1:{s:18:"background_display";s:4:"tile";}}}}s:5:"grids";a:2:{i:0;a:2:{s:5:"cells";i:1;s:5:"style";a:0:{}}i:1;a:2:{s:5:"cells";i:3;s:5:"style";a:2:{s:7:"padding";s:17:"0px 60px 0px 60px";s:18:"background_display";s:4:"tile";}}}s:10:"grid_cells";a:4:{i:0;a:4:{s:4:"grid";i:0;s:5:"index";i:0;s:6:"weight";i:1;s:5:"style";a:0:{}}i:1;a:4:{s:4:"grid";i:1;s:5:"index";i:0;s:6:"weight";d:0.1564811818250000097219043482255074195563793182373046875;s:5:"style";a:0:{}}i:2;a:4:{s:4:"grid";i:1;s:5:"index";i:1;s:6:"weight";d:0.58460762103899999164724476941046305000782012939453125;s:5:"style";a:0:{}}i:3;a:4:{s:4:"grid";i:1;s:5:"index";i:2;s:6:"weight";d:0.2589111971349999929969953882391564548015594482421875;s:5:"style";a:0:{}}}}
apss_content_flag:
0

IFAPP

INTERNATIONAL FEDERATION OF ASSOCIATIONS OF PHARMACEUTICAL PHYSICIANS & PHARMACEUTICAL MEDICINE

Log In

Create an account